About Adipogen Life Sciences
AdipoGen Life Sciences develops research reagents and assay tools for the study of inflammation, immune responses and immunometabolism. Operating from headquarters in the USA and Switzerland, the company focuses on scientific areas including inflammasome biology, innate immunity, B and T cell regulation, neuroinflammation, obesity and metabolic disease, immuno-oncology, infectious disease and neurodegeneration. Its expertise spans antibody generation, recombinant protein production, ELISA assay development and small molecule discovery, enabling researchers to investigate cellular signalling pathways, immune mechanisms and disease-associated biomarkers in both basic and translational research.
The company’s portfolio includes monoclonal, polyclonal and recombinant antibodies, recombinant proteins, ELISA kits, biochemicals, natural products and rare antibiotics. Notable product families include InVivoKine™ cytokines and immune modulators, B-Xpander™ cell culture reagents, functional antibodies and immunoassays designed for biomarker detection and pathway analysis. These products support workflows in immunology, cancer research, autoimmune disease, metabolism, stem cell biology, antimicrobial resistance and cell therapy research. AdipoGen also provides specialised development and validation services for proteins, antibodies and assays.
Europa Biosite subsidiaries distribute AdipoGen Life Science products across Denmark, Estonia, Finland, Germany, Iceland, Latvia, Lithuania, Norway and Sweden.